Comments for OSIR - Stockpickr! Your Source for Stock Ideas

Comments for OSIR

Added By	Comments	Type	Date Added
Dan Jacobs	stem cell / defense /biotech play featured in Investors Business Daily. The company uses adult stem cells to repair GI tract after radiation exposure.	Love	January 14, 2008
Dan Jacobs	stem cell / defense /biotech play featured in Investors Business Daily. The company uses adult stem cells to repair GI tract after radiation exposure.	Love	January 14, 2008
gman0412	i think it a good stock,its at the low and got fast	Love	December 07, 2007
rentman	news	Love	August 23, 2007
Jamie Fitch	Osiris Therapeutics is focusing on using mesenchymal stem cells (MSCs). these cells come from adult bone marrow. They are interesting in that they are not highly specialized and can be converted into a variety of connective tissues using specific enzymes (they are the adult stell cells most similar to embyronic stem cells). Osiris is currently looking to use MSCs to treat inflammatory diseases, heart disease, and to aid in spinal fusions. They already have one product in the market (Osteocel) for spinal fusions. This product helps create the spongy interior of bones and aids in fusion. It is the only stem cell treatment that is on the market (as of Dec 06). Additionally, they have three other products in phase I-III stage clinical trials. This bodes well for the company. While their financials have been ugly of late, at least this company has a treatment on the market. Additionally, research approaching advanced trials on diseases such as Crohn's disease could pay off in the somewhat near future. Finally, it has been able to harbor MSCs to create a wide variety of tissues, much like embryonic cells will be able to do. This makes me believe they will be able to adapt and use the new + presumably more potent cells quickly. They have shown the ability to get a stem cell product to the market, which is extremely challenging. Unlike STEM, this company will rely more on its products and less on its potential to convince investors to back them. They are probably the furthest along of all of companies I will be considering in stem cell therapy techniques.	Love	May 17, 2007
Barrons	"Provacel stem-cell treatment for heart disease."	Love	May 05, 2007
mldillon	BSR pick, mesenchymal cell technology, clinical therapeutic trials	Love	April 18, 2007
Calculatorci	Stem Cell,Cardiac Play	Love	April 09, 2007
Pam	-50%	Love	March 10, 2007
herb111	medical research interested in stem cell research	Love	January 25, 2007
herb111	medical research interested in stem cell research	Love	January 25, 2007
Cor Gonzola	Leading stemcell company has serious upside potenial because of products in pipeline and as takeover target.	Love	January 23, 2007
Logan-san	With monstrous run of late, it may be getting toppy, but has four shots on goal and is leading the way in the promising field of stem cell diagnostics and therapeutics	Love	January 18, 2007